This section of the FEDERAL REGISTER contains notices to the public of the proposed issuance of rules and regulations. The purpose of these notices is to give interested persons an opportunity to participate in the rule making prior to the adoption of the final rules. 

# Proposed Rules Federal Register 

### 13592

Vol. 79, No. 47

Tuesday, March 11, 2014

**DEPARTMENT OF TRANSPORTATION**

**Federal Aviation Administration**

**14 CFR Part 39**

**[Docket No. FAA–2014–0128; Directorate Identifier 2013–NM–133–AD]** 

**RIN 2120–AA64**

**Airworthiness Directives; The Boeing Company Airplanes** 

Correction

In proposed rule document 2014– 04568, appearing on pages 11725 through 11728 in the issue of Monday, March 3, 2014, make the following correction:

On page 11725, in the third column, in the third line of the **SUMMARY**
, ‘‘Boeing Company Model airplanes’’ should read ‘‘Boeing Company Model 777 airplanes’’.

[FR Doc. C1–2014–04568 Filed 3–10–14; 8:45 am]

**BILLING CODE 1505–01–D**

**DEPARTMENT OF TRANSPORTATION**

**Federal Aviation Administration**

**14 CFR Parts 121, 135, and 142**

**[AC 120–UPRT and AC 120–109A]**

**Advisory Circular for Upset Prevention and Recovery Training and Advisory**  **Circular for Stall Prevention and Recovery Training** 

**AGENCY :**  Federal Aviation Administration (FAA), Department of Transportation (DOT).

**ACTION :**  Notice of availability of proposed Advisory Circular for Upset Prevention and Recovery Training and proposed revision to Advisory Circular for Stall Prevention and Recovery Training, request for comment.

**SUMMARY :**  The Federal Aviation Administration (FAA) is announcing the availability of proposed Advisory Circulars (AC) 120–UPRT and 120– 109A. AC 120–UPRT provides recommended practices and guidance for academic and flight simulation training device (FSTD) training for pilots to prevent developing upset conditions and ensure correct and consistent recovery responses to upsets. AC 120–109A provides guidance and best practices for training, testing, and checking for pilots to ensure correct responses to impending and full stalls.

**DATES :**  Written comments must be received on or before May 12, 2014.

**ADDRESSES :**  Send comments identified by AC 120–UPRT or AC 120–109A using any of the following methods:

• Aviation Safety Draft Document Open for Comment Web site: Go to http://www.faa.gov/aircraft/draft

_ docs/ afs

_ac/ and follow the online instructions for sending your comments electronically.

• Mail: Send comments to 1625 K Street NW., Suite 300, Washington, DC
20006.

• Fax: Fax comments to 202–223– 4615. Attn: Susan Hill.

• Hand Delivery: Bring comments to the 1625 K Street NW., Suite 300, Washington, DC between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays.

**FOR FURTHER INFORMATION CONTACT :**  Robyn LaPorte, Air Transportation Division, Flight Standards Service, Federal Aviation Administration, 800 Independence Avenue SW., Washington, DC 20591; telephone: 202– 267–8166; facsimile: 202–267–5229; email: robyn.laporte@faa.gov. Background

These draft ACs provide guidance regarding the new training requirements contained in the Qualification, Service, and Use of Crewmembers and Aircraft Dispatchers final rule published November 12, 2013 (FAA Docket FAA– 2008–0677). Advisory Circular 120–UPRT

The primary goal of this proposed AC is to provide recommended practices and guidance for academic and flight simulation training device (FSTD) training for pilots to prevent developing upset conditions and ensure correct and consistent recovery responses to upsets. This AC was developed based on a review of recommended practices developed by major airplane manufacturers, labor organizations, air carriers, training organizations, simulator manufacturers, and industry representative organizations. This AC provides guidance to Title 14 Code of Federal Regulations (14 CFR) part 121 air carriers implementing the regulatory requirements of § § 121.419, 121.423, 121.424, and 121.427. Core principles of this AC include:

• Enhanced instructor training on the limitations of simulation.

• Comprehensive pilot academic training on aerodynamics.

• Early recognition of divergence from intended flight path.

• Upset prevention through improvements in manual handling skills.

• Progressive intervention strategies for the pilot monitoring. Advisory Circular 120–109A

The primary goal of this proposed AC revision is to provide guidance and best practices for training, testing, and checking for pilots to ensure correct responses to impending and full stalls. This AC was developed based on a review of recommended practices developed by major airplane manufacturers, labor organizations, air carriers, training organizations, simulator manufacturers, and industry representative organizations. Core principles of this Advisory Circular include:

• Reducing angle of attack is the most important pilot action in an impending or full stall.

• Pilot training should emphasize teaching the same recovery technique for impending stalls and full stalls.

• Evaluation criteria for a recovery from an impending stall should not include a predetermined value for altitude loss. Instead, criteria should consider the multitude of external and internal variables which affect the recovery altitude.

• Once the stall recovery procedure is mastered by maneuver-based training, stall prevention training should include realistic scenarios that could be encountered in operational conditions, including impending stalls with the autopilot engaged and at high altitudes.

• Full stall training should be led by the instructor, but must allow the pilot to experience the associated flight dynamics and execute a recovery.

The agency will consider all comments received by May 12, 2014. Comments received after that date may be considered if consideration will not


### 13593 Federal Register / Vol. 79, No. 47 / Tuesday, March 11, 2014 / Proposed Rules

delay agency action on the review. A copy of the advisory circulars is available for review at http:// www.faa.gov/aircraft/draft

_ docs/ afs

_ac/.

Issued in Washington, DC on March 5,
2014. John S. Duncan, Deputy Director, Flight Standards Service.
[FR Doc. 2014–05287 Filed 3–10–14; 8:45 am]

**BILLING CODE 4910–13–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Food and Drug Administration**

**21 CFR Parts 16 and 112**

**[Docket No. FDA–2011–N–0921]**

**RIN 0910–AG35**

**Environmental Impact Statement for the Proposed Rule, Standards for**  **Growing, Harvesting, Packing, and Holding of Produce for Human**  **Consumption; Public Meeting on Scoping of Environmental Impact**  **Statement and Extension of Comment Period for Environmental Impact**  **Statement**

**AGENCY :**  Food and Drug Administration, HHS.

**ACTION :**  Notification of public scoping meeting; extension of comment period for the Environmental Impact Statement.

**SUMMARY :**  The Food and Drug Administration (FDA or we) is announcing the extension of the public scoping period for Environmental Impact Statement (EIS), as well as a public scoping meeting to discuss the scope of the EIS for the proposed rule to establish standards for growing, harvesting, packing, and holding of produce for human consumption. FDA is holding a public scoping meeting as part of our ongoing efforts to seek public input on the issues and alternatives that we should consider when preparing the EIS and to provide information about the EIS process (including how to submit comments, data, and other information to the rulemaking docket), to solicit oral stakeholder and public comments on the scope of the EIS, and to respond to questions about the EIS.

**DATES :**  See section II, ‘‘How to Participate in the Public Meeting’’ in the

**SUPPLEMENTARY INFORMATION** section of this document for date and time of the public meeting, closing dates for advance registration, and information on deadlines for submitting either electronic or written comments to FDA’s Division of Dockets Management.

Comments on the scope of issues the Agency should include in the EIS may be submitted until April 18, 2014.

**ADDRESSES :**  See section II, ‘‘How to Participate in the Public Meeting’’ in the

**SUPPLEMENTARY INFORMATION** section of this document. You may submit comments on the scope of issues the Agency should include in the EIS, identified by Docket No. FDA–2011–N– 0921 and/or Regulatory Information Number (RIN) 0910–AG35, by any of the following methods:

Electronic Submissions

Submit electronic comments in the following way:

• Federal eRulemaking Portal: http:// www.regulations.gov. Follow the instructions for submitting comments.

Written Submissions

Submit written submissions in the following ways:

• Mail/Hand delivery/Courier (for paper submissions): Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

Instructions: All submissions received must include the Agency name and Docket No. FDA–2011–N–0921, and RIN 0910–AG35 for this rulemaking. All comments received may be posted without change to http:// www.regulations.gov, including any personal information provided. For additional information on submitting comments, see the ‘‘Request for Comments’’ heading of the

**SUPPLEMENTARY INFORMATION** section of this document.

Docket: For access to the docket to read background documents or comments received, go to http:// www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the ‘‘Search’’ box and follow the prompts and/or go to the Division of Dockets Management, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

**FOR FURTHER INFORMATION CONTACT :**  For questions about registering for the meeting, to register by phone, or to submit a notice of participation by mail, FAX or email: Rick Williams, c/o FDA EIS, 72 Loveton Circle, Sparks, MD 21152, 410–316–2377; FAX: 410–472– 3289, email: RWilliams@jmt.com

.

For general questions about the meeting, to request an opportunity to make an oral presentation at the public meeting, to submit the full text, comprehensive outline, or summary of an oral presentation, or for special accommodations due to a disability: Cynthia Wise, Center for Food Safety and Applied Nutrition (HFS–009), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, 240–402–1357, email: cynthia.wise@ fda.hhs.gov

.

For further information about comments for the docket: Annette McCarthy, Center for Food Safety and Applied Nutrition (HFS–205), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, 240–
402–1200.

**SUPPLEMENTARY INFORMATION :**  I. Background

The FDA Food Safety Modernization Act (FSMA) (Pub. L. 111–353), signed into law by President Obama on January 4, 2011, enables FDA to better protect public health by helping to ensure the safety and security of the food supply. FSMA amends the Federal Food, Drug, and Cosmetic Act (the FD&C Act) to establish the foundation of a modernized, prevention-based food safety system. As part of our implementation of FSMA, we published the Proposed Rule, Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption (hereafter referred to as ‘‘the Produce Safety proposed rule’’) to establish science-based minimum standards for the safe growing, harvesting, packing, and holding of produce (78 FR 3503, January 16, 2013). We recently announced plans to propose revised rule language for key parts of the Produce Safety proposed rule, including those related to water quality and the use of raw manure and compost (Ref. 1).

In publishing the Produce Safety proposed rule, we relied on a categorical exclusion from the need to prepare an Environmental Assessment or EIS under 21 CFR 25.30(j) (78 FR 3503 at 3616). However, on August 19, 2013, we issued a Notice of Intent to Prepare an Environmental Impact Statement for the Proposed Rule, Standards for Growing, Harvesting, Packing, and Holding of Produce for Human Consumption (NOI), based on additional information, including comments received, and upon further analysis. In the NOI, we explained that FDA has determined that the proposed action may significantly affect the quality of the human environment (21 CFR 25.22(b)), and therefore, an EIS is necessary for the final rule (78 FR 50358, August 19, 2013). In the NOI, FDA also announced the beginning of the scoping process and solicited public comments to identify issues to be analyzed in an EIS. The NOI asked for public comment by